NIH launches early-stage yellow fever vaccine trial

( < i > NIH/National Institute of Allergy and Infectious Diseases < /i > ) The National Institute of Allergy and Infectious has begun an early-stage clinical trial of an investigational vaccine designed to protect against yellow fever virus. The Phase 1 study is evaluating whether an experimental vaccine developed by the Danish biopharmaceutical company Bavarian Nordic is safe, tolerable and has the potential to prevent yellow fever virus infection.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news